MREO 内幕交易 Insider Trades
MREO 的 SEC Form 4 内幕交易记录 SEC Form 4 insider transaction records for MREO
总交易 Total
29
买入 Buys
0
买入总额 Total Buys
-
卖出总额 Total Sells
-
| 信号 Signal | 内幕人 Insider | 职位 Title | 方向 Type | 股数 Shares | 价格 Price | 金额 Amount | 日期 Date | 信号原因 Reasons |
|---|---|---|---|---|---|---|---|---|
| ★★★★★(0) | JENKINS ANNALISA | - | 卖出 Sell | 106,848 | - | - | 2026-02-26 | |
| ★★★★★(0) | JACQUET PIERRE | - | 卖出 Sell | 106,848 | - | - | 2026-02-26 | |
| ★★★★★(0) | BENDER JEREMY | - | 卖出 Sell | 117,533 | - | - | 2026-02-26 | |
| ★★★★★(0) | SHAMES DANIEL | - | 卖出 Sell | 66,000 | - | - | 2026-02-26 | |
| ★★★★★(0) | EKBLOM ANDERS | - | 卖出 Sell | 66,000 | - | - | 2026-02-26 | |
| ★★★★★(0) | YOSKOWITZ MARC J | - | 卖出 Sell | 66,000 | - | - | 2026-02-26 | |
| ★★★★★(0) | WYZGA MICHAEL S | - | 卖出 Sell | 66,000 | - | - | 2026-02-26 | |
| ★★★★★(0) | BENDER JEREMY | - | 卖出 Sell | 66,000 | - | - | 2026-02-26 | |
| ★★★★★(0) | JENKINS ANNALISA | - | 卖出 Sell | 66,000 | - | - | 2026-02-26 | |
| ★★★★★(0) | EKBLOM ANDERS | - | 卖出 Sell | 133,560 | - | - | 2026-02-26 | |
| ★★★★★(0) | YOSKOWITZ MARC J | - | 卖出 Sell | 96,163 | - | - | 2026-02-26 | |
| ★★★★★(0) | PAKIANATHAN DEEPIKA | - | 卖出 Sell | 66,000 | - | - | 2026-02-26 | |
| ★★★★★(0) | SHAMES DANIEL | - | 卖出 Sell | 96,163 | - | - | 2026-02-26 | |
| ★★★★★(0) | JACQUET PIERRE | - | 卖出 Sell | 66,000 | - | - | 2026-02-26 | |
| ★★★★★(0) | LEWICKI JOHN A. | Chief Scientific Officer | 卖出 Sell | 139,913 | - | - | 2026-02-01 | |
| ★★★★★(0) | SCOTS-KNIGHT DENISE | Chief Executive Officer | 卖出 Sell | 345,000 | - | - | 2026-02-01 | |
| ★★★★★(0) | LEWICKI JOHN A. | Chief Scientific Officer | 卖出 Sell | 46,637 | - | - | 2026-02-01 | |
| ★★★★★(0) | FOX CHRISTINE ANN | Chief Financial Officer | 卖出 Sell | 105,250 | - | - | 2026-02-01 | |
| ★★★★★(0) | HUGHES-WILSON ALEXANDRA | Chief Patient Access and Commercial Planning | 卖出 Sell | 195,000 | - | - | 2026-02-01 | |
| ★★★★★(0) | SERMON CHARLES | General Counsel | 卖出 Sell | 315,750 | - | - | 2026-02-01 | |
| ★★★★★(0) | SERMON CHARLES | General Counsel | 卖出 Sell | 295,000 | - | - | 2026-02-01 | |
| ★★★★★(0) | SCOTS-KNIGHT DENISE | Chief Executive Officer | 卖出 Sell | 480,000 | - | - | 2026-02-01 | |
| ★★★★★(0) | SCOTS-KNIGHT DENISE | Chief Executive Officer | 卖出 Sell | 1,035,000 | - | - | 2026-02-01 | |
| ★★★★★(0) | HUGHES-WILSON ALEXANDRA | Chief Patient Access and Commercial Planning | 卖出 Sell | 61,250 | - | - | 2026-02-01 | |
| ★★★★★(0) | FOX CHRISTINE ANN | Chief Financial Officer | 卖出 Sell | 315,750 | - | - | 2026-02-01 | |
| ★★★★★(0) | HUGHES-WILSON ALEXANDRA | Chief Patient Access and Commercial Planning | 卖出 Sell | 183,750 | - | - | 2026-02-01 | |
| ★★★★★(0) | FOX CHRISTINE ANN | Chief Financial Officer | 卖出 Sell | 280,000 | - | - | 2026-02-01 | |
| ★★★★★(0) | LEWICKI JOHN A. | Chief Scientific Officer | 卖出 Sell | 145,000 | - | - | 2026-02-01 | |
| ★★★★★(0) | SERMON CHARLES | General Counsel | 卖出 Sell | 105,250 | - | - | 2026-02-01 |